Slideset
View More
Slides from the major depressive disorder presentation at the 9th Annual Mood Disorders Summit 2022.
An expert reviews the limitations of monoaminergic antidepressants in major depression, evidence for use of mood-stabilizing agents and second-generation antipsychotics for the treatment of unipolar depression, and considerations for tailoring therapy to specific patients.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.